Preservon

Preservon® Allograft Bio-Implant Preservation Technology
Ambient-temperature preservation that saves valuable OR time and alleviates brittleness associated with other methods, while preserving biomechanical strength. Download the Preservon Brochure
Preservon is a proprietary, glycerol-based preservation solution that allows allograft bio-implants to be stored in a fully hydrated state at ambient temperature. This eliminates the need to freeze or freeze-dry allograft bio-implants, doing away with lengthy thawing and rehydration times in the OR.
Glycerol, the active ingredient in Preservon, acts as a humectant, maintaining the moisture within the allograft, while providing a bacteriostatic environment. These properties allow ambient temperature storage of the allograft without decay. Widely used as a food additive, glycerol since 1991 has been used as a carrier in commercially available osteobiologics products such as Optium DBM® to enhance handling characteristics.
Testing conducted both by LifeNet Health and independent sources, including biocompanitibility, osteoconductivity, and biomechanical analyses, have found the safety and performance of Preservon-treated and frozen or freeze-dried preserved allograft bio-implants to be comparable.1
What are the benefits to my patients, hospitals and me?
Your patients receive allograft bio-implants that offer uncompromised safety and performance, allowing them to resume a higher level of physical activity. For hospitals and surgeons, Preservon reduces costly OR time and offers a level of convenience not available with any other allografts. Preservon-treated allografts are packaged in the same PETG tray packaging currently used for freeze-dried allografts provided by LifeNet Health.
Why is this better than other options available?
It’s much more efficient and convenient than conventional preservation methods allow. Frozen or freeze-dried allografts can require up to 60 minutes to thaw or re-hydrate, compared to as little as 30 seconds for Preservon-treated allograft bio-implants, while reducing the potential for brittle product.